ADCIRCA

Medicinal product

(Invented) name

ADCIRCA

Active substance (s)

Tadalafilis

Strength

2 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE08, Tadalafil

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2008-10-01

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Oral suspension	1 ml
Tadalafilis	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110474	96584	1096584	buteliukas	220 ml N1 (švirkštas ir į buteliuką įspaudžiamas adapteris)		Receptinis	EU/1/08/476/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2008-10-01	Registruotas